155 related articles for article (PubMed ID: 2819750)
21. Monitoring of serum neopterin levels for diagnosis of acute rejection of renal allografts.
Reibnegger G; Fuchs D; Hausen A; Werner ER; Werner-Felmayer G; Wachter H
Nephron; 1989; 52(1):100. PubMed ID: 2651945
[No Abstract] [Full Text] [Related]
22. Comparison of serum neopterin levels and spontaneous blastogenesis in monitoring of kidney graft recipients.
Pohanka E; Zlabinger GJ; Mayer G; Woloszcsuk W; Kovarik J; Smolen J; SteffenC
Transplant Proc; 1988 Feb; 20(1):110-5. PubMed ID: 3278451
[No Abstract] [Full Text] [Related]
23. Monitoring of heart allograft rejection by simultaneous measurement of serum beta 2-microglobulin and urinary neopterin.
Schmitt F; Myara I; Benoit MO; Guillemain R; Amrein C; Dreyfus G; Paris M; Moatti N
Ann Biol Clin (Paris); 1989; 47(5):237-41. PubMed ID: 2662838
[TBL] [Abstract][Full Text] [Related]
24. [Neopterin in the serum and urine in the differential diagnosis of disorders of kidney function following kidney transplantation].
Wolf J; Musch E; Neuss H; Klehr U
Klin Wochenschr; 1987 Mar; 65(5):225-31. PubMed ID: 3553724
[TBL] [Abstract][Full Text] [Related]
25. Neopterin changes after clinical heart transplantation.
Wang SS; Chu SH; Ko WJ
Transplant Proc; 1996 Jun; 28(3):1730-2. PubMed ID: 8658860
[No Abstract] [Full Text] [Related]
26. Immune activation and enhanced urinary zinc concentrations in allograft recipients.
Melichar B; Aichberger C; Artner-Dworzak E; Weiss G; Margreiter R; Wachter H; Fuchs D
Presse Med; 1994 Apr; 23(15):702-6. PubMed ID: 8072975
[TBL] [Abstract][Full Text] [Related]
27. Active CMV and EBV infections in renal transplant recipients with unexplained fever and elevated serum creatinine.
Hasannia T; Moosavi Movahed SM; Vakili R; Rafatpanah H; Hekmat R; Valizadeh N; Rezaee SA
Ren Fail; 2016 Oct; 38(9):1418-1424. PubMed ID: 27484706
[TBL] [Abstract][Full Text] [Related]
28. Comparison of serum neopterin levels and urinary neopterin excretion in renal allograft recipients.
Aulitzky WE; Tilg H; Niederwieser D; Riccabona G; Obendorf L; Margreiter R; Pfaller W; Huber C
Clin Nephrol; 1988 May; 29(5):248-52. PubMed ID: 3293855
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of combination of biologic markers (C-reactive protein, neopterin, and microalbuminuria) in the follow-up of kidney transplantation in children: four years of clinical experience.
Fischbach M; Desprez P; Mengus L; Christman D; Marcellin L; Chenard MP; Hamel G; Koehl C; Simeoni U; Boudjema K
Transplant Proc; 1994 Feb; 26(1):72-4. PubMed ID: 8109029
[No Abstract] [Full Text] [Related]
30. Immunosuppression by Cyclosporin A in human renal transplant recipients.
Ringdén O; Bergstrand A; Collste H; Grimfors G; Lundgren G; Groth CG
Scand J Urol Nephrol Suppl; 1981; 64():220-9. PubMed ID: 6755683
[TBL] [Abstract][Full Text] [Related]
31. Biliary and urinary neopterin concentrations in monitoring liver-allograft recipients.
Hausen A; Aichberger C; Königsrainer A; Weiss G; Margreiter R; Wachter H
Clin Chem; 1993 Jan; 39(1):45-7. PubMed ID: 8380366
[TBL] [Abstract][Full Text] [Related]
32. Monitoring of the serum neopterin/creatinine ratio in renal transplantation.
Hacini D; Guerin C; Berthoux P; Ville G; Berthoux F
Transplant Proc; 1987 Feb; 19(1 Pt 3):2185-6. PubMed ID: 3274488
[No Abstract] [Full Text] [Related]
33. Pancreas-specific protein (PASP), serum amyloid A (SAA), and neopterin (NEOP) in the diagnosis of rejection after simultaneous pancreas and kidney transplantation.
Müller TF; Trösch F; Ebel H; Grüssner RW; Feiber H; Göke B; Greger B; Lange H
Transpl Int; 1997; 10(3):185-91. PubMed ID: 9163857
[TBL] [Abstract][Full Text] [Related]
34. Cytomegalovirus infection and disease in renal transplant patients treated with cyclosporin. A prospective study.
Bosch FH; Hoitsma AJ; Janssen HP; van Loon AM; Koene RA
Transpl Int; 1989 Aug; 2(2):92-5. PubMed ID: 2551314
[TBL] [Abstract][Full Text] [Related]
35. Neopterin excretion after liver transplantation and its value in differential diagnosis of complications.
Tilg H; Vogel W; Aulitzky WE; Schönitzer D; Margreiter R; Dietze O; Judmaier G; Wachter H; Huber C
Transplantation; 1989 Oct; 48(4):594-9. PubMed ID: 2552627
[TBL] [Abstract][Full Text] [Related]
36. Value of circulating immune parameters in renal transplantation.
Rebhandl W; Felberbauer FX; Resch S; Paya K; Schneider B; Riegler-Keil M; Mühlbacher F; Stockenhuber F
Transplant Proc; 1997 May; 29(3):1881-5. PubMed ID: 9142311
[No Abstract] [Full Text] [Related]
37. The anaphylatoxin C5a, a new parameter in the diagnosis of renal allograft rejection.
Müller TF; Neumann CM; Greb C; Kraus M; Lange H
Transpl Int; 1996; 9 Suppl 1():S58-62. PubMed ID: 8959792
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation.
Tilg H; Vogel W; Aulitzky WE; Herold M; Königsrainer A; Margreiter R; Huber C
Transplantation; 1990 Jun; 49(6):1074-80. PubMed ID: 2163132
[TBL] [Abstract][Full Text] [Related]
39. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
[TBL] [Abstract][Full Text] [Related]
40. Serum neopterin as an indicator of increased risk of renal allograft rejection.
Carey BS; Jain R; Adams CL; Wong KY; Shaw S; Tse WY; Kaminski ER
Transpl Immunol; 2013 Mar; 28(2-3):81-5. PubMed ID: 23481351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
